Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced results from STRIDE-8, a Phase 3 trial evaluating CAPVAXIVE™ (Pneu...
“Resolian merges expertise from Alliance Pharma and Drug Development Solutions — two leading providers of bioanalysis and analytical sciences &...
Combined broad and differentiated portfolio with trusted technologies and commercial and service organizations Customers will have simpler and greater a...
Dr. Moore performed a 3-level ACDF procedure with theZSFab Cervical Interbody System at The Surgical Hospital of Oklahoma. This was the second case in...
According to the Global Cancer Observatory, in Saudi Arabia there are 830 new kidney cancer cases were registered in 2018, furthermore, 249 people were d...
LTL’s Reorganization Plan Has Significant Support From Claimants The Plan Includes LTL’s Present Value Commitment of $8.9 Billion Payable...
© 2024 Biopharma Boardroom. All Rights Reserved.
